id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2016-N-3818-0197,FDA,FDA-2016-N-3818,Reference 86 Content and Format of Substantial Equivalence Reports Final Rule Final Regulatory Impact Analysis re: Content and Format of Substantial Equivalence Reports; Food and Drug Administration Actions on Substantial Equivalence Reports,Supporting & Related Material,Background Material,2021-10-07T04:00:00Z,2021,10,,,2021-10-07T20:20:44Z,,0,0,0900006484dbe831
FDA-2016-N-3818-0196,FDA,FDA-2016-N-3818,Reference 67 Assessment-of-Hazards to Occupants from Smoke 2016 re: Content and Format of Substantial Equivalence Reports; Food and Drug Administration Actions on Substantial Equivalence Reports,Supporting & Related Material,Background Material,2021-10-06T04:00:00Z,2021,10,,,2021-10-06T12:09:11Z,,0,0,0900006484dbb620
FDA-2016-N-3818-0178,FDA,FDA-2016-N-3818,Reference 15 Cigarette Yields and Human Exposure-A Comparison...Testing Regimens 2006 re: Content and Format of Substantial Equivalence Reports; Food and Drug Administration Actions on Substantial Equivalence Reports,Supporting & Related Material,Background Material,2021-10-05T04:00:00Z,2021,10,,,2021-10-05T19:36:49Z,,0,0,0900006484dbae90
FDA-2016-N-3818-0188,FDA,FDA-2016-N-3818,FRIA Ref 3 FDA Report to House Committee on Appropriations 2018 re: Content and Format of Substantial Equivalence Reports; Food and Drug Administration Actions on Substantial Equivalence Reports,Supporting & Related Material,Background Material,2021-10-05T04:00:00Z,2021,10,,,2021-10-05T20:03:45Z,,0,0,0900006484dba8da
FDA-2016-N-3818-0176,FDA,FDA-2016-N-3818,Content and Format of Substantial Equivalence Reports; Food and Drug Administration Actions on Substantial Equivalence Reports,Rule,Final Rule,2021-10-05T04:00:00Z,2021,10,2021-10-05T04:00:00Z,,2021-10-05T20:23:28Z,2021-21009,0,0,0900006484dba96e
FDA-2016-N-3818-0180,FDA,FDA-2016-N-3818,Reference 27. ISO 3308-2012. Routine analytical cigarette-smoking machine - Definitions and standard conditions re: Content and Format of Substantial Equivalence Reports; Food and Drug Administration Actions on Substantial Equivalence Reports,Supporting & Related Material,Background Material,2021-10-05T04:00:00Z,2021,10,,,2021-10-05T19:40:46Z,,0,0,0900006484dbaeaa
FDA-2016-N-3818-0195,FDA,FDA-2016-N-3818,Reference 79 Nitrate Concentration Changes During Senescence and Air Curing of Burley Tobacco 1982 re: Content and Format of Substantial Equivalence Reports; Food and Drug Administration Actions on Substantial Equivalence Reports,Supporting & Related Material,Background Material,2021-10-05T04:00:00Z,2021,10,,,2021-10-05T20:14:47Z,,0,0,0900006484dba8ae
FDA-2016-N-3818-0191,FDA,FDA-2016-N-3818,FRIA Ref 6a May 2018 OES Wage Estimates - NAICS 312000 Beverage and Tobacco Product Manufacturing re: Content and Format of Substantial Equivalence Reports; Food and Drug Administration Actions on Substantial Equivalence Reports,Supporting & Related Material,Background Material,2021-10-05T04:00:00Z,2021,10,,,2021-10-05T20:07:56Z,,0,0,0900006484dbb12e
FDA-2016-N-3818-0182,FDA,FDA-2016-N-3818,Reference 31 In Vitro Study of Nicotine Release from Smokeless Tobacco 1998 re: Content and Format of Substantial Equivalence Reports; Food and Drug Administration Actions on Substantial Equivalence Reports,Supporting & Related Material,Background Material,2021-10-05T04:00:00Z,2021,10,,,2021-10-05T19:44:15Z,,0,0,0900006484dbae93
FDA-2016-N-3818-0187,FDA,FDA-2016-N-3818,FRIA Ref 2 84 FR 12740 re: Content and Format of Substantial Equivalence Reports; Food and Drug Administration Actions on Substantial Equivalence Reports,Supporting & Related Material,Background Material,2021-10-05T04:00:00Z,2021,10,,,2021-10-05T19:57:17Z,,0,0,0900006484dbae71
FDA-2016-N-3818-0190,FDA,FDA-2016-N-3818,FRIA Ref 5 Memo_SEApril5 re: Content and Format of Substantial Equivalence Reports; Food and Drug Administration Actions on Substantial Equivalence Reports,Supporting & Related Material,Background Material,2021-10-05T04:00:00Z,2021,10,,,2021-10-05T20:06:17Z,,0,0,0900006484dbb12d
FDA-2016-N-3818-0185,FDA,FDA-2016-N-3818,SE FRIA References List - re: Content and Format of Substantial Equivalence Reports; Food and Drug Administration Actions on Substantial Equivalence Reports,Supporting & Related Material,Background Material,2021-10-05T04:00:00Z,2021,10,,,2021-10-05T19:54:56Z,,0,0,0900006484dbae6a
FDA-2016-N-3818-0186,FDA,FDA-2016-N-3818,FRIA Ref 1 SE PRIA re: Content and Format of Substantial Equivalence Reports; Food and Drug Administration Actions on Substantial Equivalence Reports,Supporting & Related Material,Background Material,2021-10-05T04:00:00Z,2021,10,,,2021-10-05T19:56:14Z,,0,0,0900006484dba8d8
FDA-2016-N-3818-0184,FDA,FDA-2016-N-3818,Reference 43 Lower Ignition Propensity re: Content and Format of Substantial Equivalence Reports; Food and Drug Administration Actions on Substantial Equivalence Reports,Supporting & Related Material,Background Material,2021-10-05T04:00:00Z,2021,10,,,2021-10-05T19:50:11Z,,0,0,0900006484dbaead
FDA-2016-N-3818-0194,FDA,FDA-2016-N-3818,FRIA Ref 8 us 6digitnaics 2012 re: Content and Format of Substantial Equivalence Reports; Food and Drug Administration Actions on Substantial Equivalence Reports,Supporting & Related Material,Background Material,2021-10-05T04:00:00Z,2021,10,,,2021-10-05T20:10:49Z,,0,0,0900006484dbaeab
FDA-2016-N-3818-0189,FDA,FDA-2016-N-3818,FRIA Ref 4 FDA Report to House Committee on Appropriations 2019 re: Content and Format of Substantial Equivalence Reports; Food and Drug Administration Actions on Substantial Equivalence Reports,Supporting & Related Material,Background Material,2021-10-05T04:00:00Z,2021,10,,,2021-10-05T20:05:18Z,,0,0,0900006484dbb12c
FDA-2016-N-3818-0177,FDA,FDA-2016-N-3818,Reference List - Substantial Equivalence Final Rule re: Content and Format of Substantial Equivalence Reports; Food and Drug Administration Actions on Substantial Equivalence Reports,Supporting & Related Material,Background Material,2021-10-05T04:00:00Z,2021,10,,,2021-10-05T19:32:58Z,,0,0,0900006484dbae54
FDA-2016-N-3818-0179,FDA,FDA-2016-N-3818,Reference 16  Physical Design Analysis and Mainstream Smoke Constituent Yields 2007 re: Content and Format of Substantial Equivalence Reports; Food and Drug Administration Actions on Substantial Equivalence Reports,Supporting & Related Material,Background Material,2021-10-05T04:00:00Z,2021,10,,,2021-10-05T19:37:49Z,,0,0,0900006484dbb135
FDA-2016-N-3818-0181,FDA,FDA-2016-N-3818,Reference 29 The Health Consequences of Smoking-The Changing Cigarette 1981 re: Content and Format of Substantial Equivalence Reports; Food and Drug Administration Actions on Substantial Equivalence Reports,Supporting & Related Material,Background Material,2021-10-05T04:00:00Z,2021,10,,,2021-10-05T19:43:01Z,,0,0,0900006484dbae92
FDA-2016-N-3818-0183,FDA,FDA-2016-N-3818,Reference 33 The Role of Filter Technology in Reduced Yield Cigarettes 2004 re: Content and Format of Substantial Equivalence Reports; Food and Drug Administration Actions on Substantial Equivalence Reports,Supporting & Related Material,Background Material,2021-10-05T04:00:00Z,2021,10,,,2021-10-05T19:46:57Z,,0,0,0900006484dbaeac
FDA-2016-N-3818-0192,FDA,FDA-2016-N-3818,FRIA Ref 6b May 2018 OES Wage Estimates - NAICS 312200 Tobacco Manufacturing re: Content and Format of Substantial Equivalence Reports; Food and Drug Administration Actions on Substantial Equivalence Reports,Supporting & Related Material,Background Material,2021-10-05T04:00:00Z,2021,10,,,2021-10-05T20:09:01Z,,0,0,0900006484dbb130
FDA-2016-N-3818-0193,FDA,FDA-2016-N-3818,FRIA Ref 7 SBA Table of Size Standards Effective Aug 19 2019 Rev re: Content and Format of Substantial Equivalence Reports; Food and Drug Administration Actions on Substantial Equivalence Reports,Supporting & Related Material,Background Material,2021-10-05T04:00:00Z,2021,10,,,2021-10-05T20:09:45Z,,0,0,0900006484dbae8c
FDA-2016-N-3818-0087,FDA,FDA-2016-N-3818,TAB A 2013-288 SE PRIA as Submitted to OMB re Memorandum to FDA DMS on SE NPRM,Supporting & Related Material,Background Material,2019-06-28T04:00:00Z,2019,6,,,2019-06-28T12:31:57Z,,0,0,0900006483d4b1f3
FDA-2016-N-3818-0086,FDA,FDA-2016-N-3818,TAB A 2013-288 SE NPRM as Submitted to OMB re Memorandum to FDA DMS on SE NPRM,Supporting & Related Material,Background Material,2019-06-28T04:00:00Z,2019,6,,,2019-06-28T12:31:44Z,,0,0,0900006483d4b1f2
FDA-2016-N-3818-0089,FDA,FDA-2016-N-3818,TAB B 2013-288 SE PRIA Track Changes re Memorandum to FDA DMS on SE NPRM,Supporting & Related Material,Background Material,2019-06-28T04:00:00Z,2019,6,,,2019-06-28T12:32:23Z,,0,0,0900006483d4b1f5
FDA-2016-N-3818-0091,FDA,FDA-2016-N-3818,TAB C 2013-288 SE PRIA as Cleared by OMB re Memorandum to FDA DMS on SE NPRM,Supporting & Related Material,Background Material,2019-06-28T04:00:00Z,2019,6,,,2019-06-28T12:32:50Z,,0,0,0900006483d4b212
FDA-2016-N-3818-0085,FDA,FDA-2016-N-3818,Memorandum to FDA DMS on SE NPRM,Other,Memorandum,2019-06-28T04:00:00Z,2019,6,2019-06-28T04:00:00Z,,2019-06-28T12:19:52Z,,0,0,0900006483d4b1f0
FDA-2016-N-3818-0090,FDA,FDA-2016-N-3818,TAB C 2013-288 SE NPRM as Cleared by OMB re Memorandum to FDA DMS on SE NPRM,Supporting & Related Material,Background Material,2019-06-28T04:00:00Z,2019,6,,,2019-06-28T12:32:36Z,,0,0,0900006483d4b1f6
FDA-2016-N-3818-0088,FDA,FDA-2016-N-3818,TAB B 2013-288 SE NPRM Track Changes re Memorandum to FDA DMS on SE NPRM,Supporting & Related Material,Background Material,2019-06-28T04:00:00Z,2019,6,,,2019-06-28T12:32:10Z,,0,0,0900006483d4b1f4
FDA-2016-N-3818-0068,FDA,FDA-2016-N-3818,Content and Format of Substantial Equivalence Reports; Food and Drug Administration Actions on Substantial Equivalence Reports; Extension of Comment Period,Proposed Rule,Extension of Comment Period,2019-06-13T04:00:00Z,2019,6,2019-06-13T04:00:00Z,2019-07-18T03:59:59Z,2019-06-13T21:14:01Z,2019-12478,0,0,0900006483d0d911
FDA-2016-N-3818-0063,FDA,FDA-2016-N-3818,Request for Extension from Pipe Tobacco Council,Other,Request for Extension,2019-06-04T04:00:00Z,2019,6,2019-06-04T04:00:00Z,,2019-06-04T16:02:50Z,,0,0,0900006483c5372c
FDA-2016-N-3818-0065,FDA,FDA-2016-N-3818,Request for Extension from Swedish Match North America LLC,Other,Request for Extension,2019-06-04T04:00:00Z,2019,6,2019-06-04T04:00:00Z,,2019-06-04T16:10:18Z,,0,0,0900006483cb009c
FDA-2016-N-3818-0064,FDA,FDA-2016-N-3818,Request for Extension from Coalition of Independent Tobacco Manufacturers of America (CITMA),Other,Request for Extension,2019-06-04T04:00:00Z,2019,6,2019-06-04T04:00:00Z,,2019-06-04T16:05:23Z,,0,0,0900006483ca162a
FDA-2016-N-3818-0066,FDA,FDA-2016-N-3818,Request for Extension from Cigar Rights of America,Other,Request for Extension,2019-06-04T04:00:00Z,2019,6,2019-06-04T04:00:00Z,,2019-06-04T16:12:21Z,,0,0,0900006483cdbfbc
FDA-2016-N-3818-0067,FDA,FDA-2016-N-3818,"Request for Extension from ITG Brands, LLC",Other,Request for Extension,2019-06-04T04:00:00Z,2019,6,2019-06-04T04:00:00Z,,2019-06-04T16:13:55Z,,0,0,0900006483cde0fe
FDA-2016-N-3818-0062,FDA,FDA-2016-N-3818,"Request for Extension from Cigar Association of America, Inc.",Other,Request for Extension,2019-06-04T04:00:00Z,2019,6,2019-06-04T04:00:00Z,,2019-06-04T16:01:22Z,,0,0,0900006483c53a00
FDA-2016-N-3818-0061,FDA,FDA-2016-N-3818,Transcript_All Tribes Call SE Proposed Rule 4-11-19,Other,Transcript(s),2019-04-17T04:00:00Z,2019,4,2019-04-17T04:00:00Z,,2019-04-17T16:33:16Z,,0,0,0900006483bb4c61
FDA-2016-N-3818-0060,FDA,FDA-2016-N-3818,55 Reference 54 SE PRIA_508c,Supporting & Related Material,Background Material,2019-04-11T04:00:00Z,2019,4,,,2019-04-11T17:25:28Z,,0,0,0900006483b85ab7
FDA-2016-N-3818-0025,FDA,FDA-2016-N-3818,"30 Reference 29 Design, Evaluation and Pharmacokinetic Study of Mucoadhesive Buccal Tablets, Lewis, 2006",Supporting & Related Material,Background Material,2019-04-02T04:00:00Z,2019,4,,,2019-04-02T15:08:14Z,,0,0,0900006483b57c4b
FDA-2016-N-3818-0021,FDA,FDA-2016-N-3818,"34 Reference 33 Determination of 14 Polycyclic Aromatic Hydrocarbons in Mainstream Smoke from Domestic Cigarettes, Ding, 2005",Supporting & Related Material,Background Material,2019-04-02T04:00:00Z,2019,4,,,2019-04-02T15:08:10Z,,0,0,0900006483b57c4f
FDA-2016-N-3818-0040,FDA,FDA-2016-N-3818,"42 Reference 41 The Pyrolysis of Non-Volatile Tobacco Ingredients Using a System that Simulate Cigarette Combustion, Baker, 2005",Supporting & Related Material,Background Material,2019-04-02T04:00:00Z,2019,4,,,2019-04-02T15:08:34Z,,0,0,0900006483b57c8b
FDA-2016-N-3818-0033,FDA,FDA-2016-N-3818,"23 Reference 22 The Role of Filter Technology in Reduced Yield Cigarettes, Taylor, 2004",Supporting & Related Material,Background Material,2019-04-02T04:00:00Z,2019,4,,,2019-04-02T15:08:21Z,,0,0,0900006483b57c2a
FDA-2016-N-3818-0028,FDA,FDA-2016-N-3818,"27 Reference 26 Effects of Product Format on Nicotine and TSNA Extraction from Snus Pouches, Gale, 2013",Supporting & Related Material,Background Material,2019-04-02T04:00:00Z,2019,4,,,2019-04-02T15:08:16Z,,0,0,0900006483b57c48
FDA-2016-N-3818-0020,FDA,FDA-2016-N-3818,"35 Reference 34 Levels of Tobacco-Specific Nitrosamines and Polycyclic Aromatic Hydrocarbons in Mainstream Smoke, Ding, 2008",Supporting & Related Material,Background Material,2019-04-02T04:00:00Z,2019,4,,,2019-04-02T15:08:10Z,,0,0,0900006483b57c50
FDA-2016-N-3818-0019,FDA,FDA-2016-N-3818,"36 Reference 35 The Generation of Formaldehyde in Cigarettes, Baker, 2006",Supporting & Related Material,Background Material,2019-04-02T04:00:00Z,2019,4,,,2019-04-02T15:08:09Z,,0,0,0900006483b57c51
FDA-2016-N-3818-0016,FDA,FDA-2016-N-3818,05 Reference 4 DRAFT FDA-3964,Supporting & Related Material,Background Material,2019-04-02T04:00:00Z,2019,4,,,2019-04-02T15:08:06Z,,0,0,0900006483b57be6
FDA-2016-N-3818-0029,FDA,FDA-2016-N-3818,"26 Reference 25 Kinetic Modeling on Drug Release from Controlled Drug Delivery Systems, Dash, 2010",Supporting & Related Material,Background Material,2019-04-02T04:00:00Z,2019,4,,,2019-04-02T15:08:17Z,,0,0,0900006483b5781c
FDA-2016-N-3818-0001,FDA,FDA-2016-N-3818,"Content and Format of Substantial Equivalence Reports; Food and Drug
Administration Actions on Substantial Equivalence Reports",Proposed Rule,Notice of Proposed Rulemaking (NPRM),2019-04-02T04:00:00Z,2019,4,2019-04-02T04:00:00Z,2019-07-18T03:59:59Z,2019-07-19T01:00:36Z,2019-05787,0,0,0900006483b571a6
FDA-2016-N-3818-0006,FDA,FDA-2016-N-3818,"15 Reference 14 The Generation of Water in the Tobacco Oven Volatile Test, Bourlas, 1980",Supporting & Related Material,Background Material,2019-04-02T04:00:00Z,2019,4,,,2019-04-02T15:07:57Z,,0,0,0900006483b57c07
FDA-2016-N-3818-0058,FDA,FDA-2016-N-3818,"02 Reference 1 Application, function, and effects of menthol in cigarettes a survey of tobacco industry documents, Wayne, 2004",Supporting & Related Material,Background Material,2019-04-02T04:00:00Z,2019,4,,,2019-04-02T15:09:42Z,,0,0,0900006483b57be0
FDA-2016-N-3818-0056,FDA,FDA-2016-N-3818,04 Reference 3 DRAFT FDA-3965,Supporting & Related Material,Background Material,2019-04-02T04:00:00Z,2019,4,,,2019-04-02T15:09:40Z,,0,0,0900006483b57be5
FDA-2016-N-3818-0027,FDA,FDA-2016-N-3818,28 Reference 27 Increased Pouch Sizes and Resulting Changes in the Amounts of Nicotine 2012,Supporting & Related Material,Background Material,2019-04-02T04:00:00Z,2019,4,,,2019-04-02T15:08:15Z,,0,0,0900006483b57c49
FDA-2016-N-3818-0044,FDA,FDA-2016-N-3818,"46 Reference 45 Control and use of Microbes in Tobacco Product Manufacturing, Geiss, 1989",Supporting & Related Material,Background Material,2019-04-02T04:00:00Z,2019,4,,,2019-04-02T15:08:37Z,,0,0,0900006483b57c91
FDA-2016-N-3818-0054,FDA,FDA-2016-N-3818,56 PRIA Ref 1 Memo_SEApril5,Supporting & Related Material,Background Material,2019-04-02T04:00:00Z,2019,4,,,2019-04-02T15:08:45Z,,0,0,0900006483b57ccd
FDA-2016-N-3818-0010,FDA,FDA-2016-N-3818,"11 Reference 10 Study on Tobacco Components Involved in Pyrolytic Generation of Selected Smoke Constituents, Torikaiu, 2005",Supporting & Related Material,Background Material,2019-04-02T04:00:00Z,2019,4,,,2019-04-02T15:08:01Z,,0,0,0900006483b57bfa
FDA-2016-N-3818-0024,FDA,FDA-2016-N-3818,"31 Reference 30 The Changing Cigarette Chemical Studies and Bioassays, Hoffman, 2001",Supporting & Related Material,Background Material,2019-04-02T04:00:00Z,2019,4,,,2019-04-02T15:08:13Z,,0,0,0900006483b57c4c
FDA-2016-N-3818-0023,FDA,FDA-2016-N-3818,"32 Reference 31 Cigarette Yields and Human Exposure A Comparison of Alternative Testing Regimens, Hammond, 2006",Supporting & Related Material,Background Material,2019-04-02T04:00:00Z,2019,4,,,2019-04-02T15:08:12Z,,0,0,0900006483b57c4d
FDA-2016-N-3818-0038,FDA,FDA-2016-N-3818,"40 Reference 39 Additives in Tobacco Products, Contribution of Carob Bean Extract, Cellulose Fibre, DKFZ, 2012",Supporting & Related Material,Background Material,2019-04-02T04:00:00Z,2019,4,,,2019-04-02T15:08:32Z,,0,0,0900006483b57880
FDA-2016-N-3818-0057,FDA,FDA-2016-N-3818,"03 Reference 2 NNitrosomorpholine and Other Volatile Nnitrosamines in Snuff Tobacco, Brunnemann, 1982",Supporting & Related Material,Background Material,2019-04-02T04:00:00Z,2019,4,,,2019-04-02T15:09:41Z,,0,0,0900006483b57be1
FDA-2016-N-3818-0034,FDA,FDA-2016-N-3818,"22 Reference 21 The Scientific Basis of Tobacco Product Regulation, WHO, 2008",Supporting & Related Material,Background Material,2019-04-02T04:00:00Z,2019,4,,,2019-04-02T15:08:22Z,,0,0,0900006483b57c29
FDA-2016-N-3818-0043,FDA,FDA-2016-N-3818,"45 Reference 44 Project Clover Marlboro Roll Your Own Report on the Microbial Analysis, Schulthess, 1984",Supporting & Related Material,Background Material,2019-04-02T04:00:00Z,2019,4,,,2019-04-02T15:08:36Z,,0,0,0900006483b57c8f
FDA-2016-N-3818-0049,FDA,FDA-2016-N-3818,"51 Reference 50 Swedish Snus and the Gothiatek Standard, Rutqvist, 2011",Supporting & Related Material,Background Material,2019-04-02T04:00:00Z,2019,4,,,2019-04-02T15:08:42Z,,0,0,0900006483b57ca6
FDA-2016-N-3818-0026,FDA,FDA-2016-N-3818,"29 Reference 28 Oral Mucosal Drug Delivery Clinical Pharmacokinetics, Zhang 2002",Supporting & Related Material,Background Material,2019-04-02T04:00:00Z,2019,4,,,2019-04-02T15:08:14Z,,0,0,0900006483b57c4a
FDA-2016-N-3818-0041,FDA,FDA-2016-N-3818,"43 Reference 42 A Literature Review of Aging and Fermentation of Tobacco, Smith, 1964",Supporting & Related Material,Background Material,2019-04-02T04:00:00Z,2019,4,,,2019-04-02T15:08:35Z,,0,0,0900006483b57c8d
FDA-2016-N-3818-0045,FDA,FDA-2016-N-3818,"47 Reference 46 pH Changes in Smokeless Tobaccos Undergoing Nitrosation During Prolonged Storage, Andersen, 1993",Supporting & Related Material,Background Material,2019-04-02T04:00:00Z,2019,4,,,2019-04-02T15:08:38Z,,0,0,0900006483b57ca0
FDA-2016-N-3818-0015,FDA,FDA-2016-N-3818,"06 Reference 5 Cigarette Rod Length and Its Impact on Serum Cotinine and Urinary Total NNAL Levels, NHANES 2007 2010, Agaku, 2014",Supporting & Related Material,Background Material,2019-04-02T04:00:00Z,2019,4,,,2019-04-02T15:08:06Z,,0,0,0900006483b57be7
FDA-2016-N-3818-0013,FDA,FDA-2016-N-3818,08 Reference 7 Trends in Nicotine Yield in Smoke 2007,Supporting & Related Material,Background Material,2019-04-02T04:00:00Z,2019,4,,,2019-04-02T15:08:04Z,,0,0,0900006483b57be9
FDA-2016-N-3818-0008,FDA,FDA-2016-N-3818,"13 Reference 12 Tobacco, Cigarettes and Cigarette Smoke An Overview, Geiss, 2007",Supporting & Related Material,Background Material,2019-04-02T04:00:00Z,2019,4,,,2019-04-02T15:07:59Z,,0,0,0900006483b57bfc
FDA-2016-N-3818-0042,FDA,FDA-2016-N-3818,"44 Reference 43 Influence of Microorganisms-Fermentation- on the Chemistry of Tobacco, Cornell, 1979",Supporting & Related Material,Background Material,2019-04-02T04:00:00Z,2019,4,,,2019-04-02T15:08:36Z,,0,0,0900006483b57c8e
FDA-2016-N-3818-0052,FDA,FDA-2016-N-3818,"54 Reference 53 Effects of Storage Conditions on Levels of Tobacco Specific N Nitrosamines, Djordjevic, 1993",Supporting & Related Material,Background Material,2019-04-02T04:00:00Z,2019,4,,,2019-04-02T15:08:44Z,,0,0,0900006483b57cc1
FDA-2016-N-3818-0004,FDA,FDA-2016-N-3818,"17 Reference 16 Effect of Cigarette Paper on Smoke Yield and Composition, Owens, 1978",Supporting & Related Material,Background Material,2019-04-02T04:00:00Z,2019,4,,,2019-04-02T15:07:56Z,,0,0,0900006483b57c0f
FDA-2016-N-3818-0050,FDA,FDA-2016-N-3818,"52 Reference 51 Formation and Analysis of Tobacco specific N nitrosamines, Brunnemann, 1996",Supporting & Related Material,Background Material,2019-04-02T04:00:00Z,2019,4,,,2019-04-02T15:08:42Z,,0,0,0900006483b57cbf
FDA-2016-N-3818-0055,FDA,FDA-2016-N-3818,57 PRIA Ref 2 BLS OES wages,Supporting & Related Material,Background Material,2019-04-02T04:00:00Z,2019,4,,,2019-04-02T15:08:46Z,,0,0,0900006483b57cce
FDA-2016-N-3818-0014,FDA,FDA-2016-N-3818,"07 Reference 6 Dynamic Behavior and Filtration of Mainstream Smoke in the Tobacco Column and Filter, Eaker, 1990",Supporting & Related Material,Background Material,2019-04-02T04:00:00Z,2019,4,,,2019-04-02T15:08:05Z,,0,0,0900006483b57be8
FDA-2016-N-3818-0012,FDA,FDA-2016-N-3818,09 Reference 8 Cigarette Pressure Drop,Supporting & Related Material,Background Material,2019-04-02T04:00:00Z,2019,4,,,2019-04-02T15:08:03Z,,0,0,0900006483b57bea
FDA-2016-N-3818-0011,FDA,FDA-2016-N-3818,"10 Reference 9 The Health Consequences of Smoking The Changing Cigarette, 1981, Report of the Surgeon General",Supporting & Related Material,Background Material,2019-04-02T04:00:00Z,2019,4,,,2019-04-02T15:08:02Z,,0,0,0900006483b57bf4
FDA-2016-N-3818-0009,FDA,FDA-2016-N-3818,"12 Reference 11 Effect of Manufacturing Variables on Cigarette Smoke Composition, Spears, 1974",Supporting & Related Material,Background Material,2019-04-02T04:00:00Z,2019,4,,,2019-04-02T15:08:00Z,,0,0,0900006483b57bfb
FDA-2016-N-3818-0018,FDA,FDA-2016-N-3818,"37 Reference 36 Preventing Tobacco Use Among Young People, Report of the Surgeon General, 1994",Supporting & Related Material,Background Material,2019-04-02T04:00:00Z,2019,4,,,2019-04-02T15:08:08Z,,0,0,0900006483b57846
FDA-2016-N-3818-0022,FDA,FDA-2016-N-3818,33 Reference 32 Physical Design Analysis and Mainstream Smoke Constituent Yields 2007,Supporting & Related Material,Background Material,2019-04-02T04:00:00Z,2019,4,,,2019-04-02T15:08:11Z,,0,0,0900006483b57c4e
FDA-2016-N-3818-0059,FDA,FDA-2016-N-3818,01 List of References,Supporting & Related Material,Background Material,2019-04-02T04:00:00Z,2019,4,,,2019-04-02T15:09:43Z,,0,0,0900006483b57bdf
FDA-2016-N-3818-0005,FDA,FDA-2016-N-3818,"16 Reference 15 Tobacco Volatiles Gas Chromatography, Coleman, 2000",Supporting & Related Material,Background Material,2019-04-02T04:00:00Z,2019,4,,,2019-04-02T15:07:57Z,,0,0,0900006483b57c08
FDA-2016-N-3818-0003,FDA,FDA-2016-N-3818,"18 Reference 17 Lower Ignition Propensity, British American Tobacco",Supporting & Related Material,Background Material,2019-04-02T04:00:00Z,2019,4,,,2019-04-02T15:07:55Z,,0,0,0900006483b57c10
FDA-2016-N-3818-0047,FDA,FDA-2016-N-3818,"49 Reference 48 Reduction of the Water Activity of Wet Snuff 259, St Charles, 1989",Supporting & Related Material,Background Material,2019-04-02T04:00:00Z,2019,4,,,2019-04-02T15:08:40Z,,0,0,0900006483b57ca3
FDA-2016-N-3818-0017,FDA,FDA-2016-N-3818,"38 Reference 37 How Tobacco Smoke Causes Disease-The Biology and Behavioral Basis, Report of the Surgeon General, 2010",Supporting & Related Material,Background Material,2019-04-02T04:00:00Z,2019,4,,,2019-04-02T15:08:07Z,,0,0,0900006483b5787e
FDA-2016-N-3818-0007,FDA,FDA-2016-N-3818,"14 Reference 13 Role of Cigarette Physical Characteristics on Smoke Composition, DeBardeleben, 1978",Supporting & Related Material,Background Material,2019-04-02T04:00:00Z,2019,4,,,2019-04-02T15:07:58Z,,0,0,0900006483b57bfd
FDA-2016-N-3818-0002,FDA,FDA-2016-N-3818,"19 Reference 18 Influence of Filter Ventilation on the Chemical Composition of Cigarette Mainstream Smoke, Adam, 2010",Supporting & Related Material,Background Material,2019-04-02T04:00:00Z,2019,4,,,2019-04-02T15:07:53Z,,0,0,0900006483b57c22
FDA-2016-N-3818-0036,FDA,FDA-2016-N-3818,"20 Reference 19 Secret Science Tobacco Industry Research on Smoking Behavior, Hammond, 2006",Supporting & Related Material,Background Material,2019-04-02T04:00:00Z,2019,4,,,2019-04-02T15:08:24Z,,0,0,0900006483b57c23
FDA-2016-N-3818-0046,FDA,FDA-2016-N-3818,48 Reference 47 The water content water activity relationship,Supporting & Related Material,Background Material,2019-04-02T04:00:00Z,2019,4,,,2019-04-02T15:08:39Z,,0,0,0900006483b57ca1
FDA-2016-N-3818-0051,FDA,FDA-2016-N-3818,"53 Reference 52 Sources of and Technical Approaches for the Abatement of Tobacco Specific Nitorsamine Formation, Fisher, 2012",Supporting & Related Material,Background Material,2019-04-02T04:00:00Z,2019,4,,,2019-04-02T15:08:43Z,,0,0,0900006483b57cc0
FDA-2016-N-3818-0032,FDA,FDA-2016-N-3818,58 PRIA Ref 3 SBA_Size_Standards_Table,Supporting & Related Material,Background Material,2019-04-02T04:00:00Z,2019,4,,,2019-04-02T15:08:19Z,,0,0,0900006483b57cd0
FDA-2016-N-3818-0035,FDA,FDA-2016-N-3818,"21 Reference 20 The Design of Cigarettes, Browne, 1990",Supporting & Related Material,Background Material,2019-04-02T04:00:00Z,2019,4,,,2019-04-02T15:08:23Z,,0,0,0900006483b57c24
FDA-2016-N-3818-0031,FDA,FDA-2016-N-3818,"24 Reference 23 Basic Principles of Cigarette Design and Function, Podraza, 2001",Supporting & Related Material,Background Material,2019-04-02T04:00:00Z,2019,4,,,2019-04-02T15:08:18Z,,0,0,0900006483b57c2b
FDA-2016-N-3818-0048,FDA,FDA-2016-N-3818,"50 Reference 49 Effect of Storage Conditions on Nitrosated, Acylated, and Oxidized Pyridine Alkaloid Derivatives, Andersen, 1989",Supporting & Related Material,Background Material,2019-04-02T04:00:00Z,2019,4,,,2019-04-02T15:08:41Z,,0,0,0900006483b57ca4
FDA-2016-N-3818-0037,FDA,FDA-2016-N-3818,"39 Reference 38 Smokeless Tobacco and Public Health-A Global Perspective, NCI, 2014",Supporting & Related Material,Background Material,2019-04-02T04:00:00Z,2019,4,,,2019-04-02T15:08:32Z,,0,0,0900006483b5787f
FDA-2016-N-3818-0039,FDA,FDA-2016-N-3818,"41 Reference 40 Pyrolysis GC MS Analysis of Guar Gum and Hydroxypropyl Guar at 300 Degrees C and 600 Degrees C, Naworal, 1990",Supporting & Related Material,Background Material,2019-04-02T04:00:00Z,2019,4,,,2019-04-02T15:08:33Z,,0,0,0900006483b57881
FDA-2016-N-3818-0030,FDA,FDA-2016-N-3818,25 Reference 24 How Do Different Cigarette Design Features Influence the Standard Tar Yields,Supporting & Related Material,Background Material,2019-04-02T04:00:00Z,2019,4,,,2019-04-02T15:08:17Z,,0,0,0900006483b5781b
FDA-2016-N-3818-0053,FDA,FDA-2016-N-3818,55 Reference 54 PRIA,Supporting & Related Material,,2019-04-02T00:00:00Z,2019,4,,,2019-04-11T17:23:11Z,,0,1,0900006483b57cc2